In eukaryotes, permanent inhibition of the nonhomologous end joining (NHEJ) repair pathway at telomeres ensures that chromosome ends do not fuse. In budding yeast, binding of Rap1 to telomere repeats establishes NHEJ inhibition. Here, we show that the Uls1 protein is required for the maintenance of NHEJ inhibition at telomeres. Uls1 protein is a non-essential Swi2/Snf2-related translocase and a Small Ubiquitin-related Modifier (SUMO)-Targeted Ubiquitin Ligase (STUbL) with unknown targets. Loss of Uls1 results in telomere-telomere fusions. Uls1 requirement is alleviated by the absence of poly-SUMO chains and by rap1 alleles lacking SUMOylation sites. Furthermore, Uls1 limits the accumulation of Rap1 poly-SUMO conjugates. We propose that one of Uls1 functions is to clear non-functional polySUMOylated Rap1 molecules from telomeres to ensure the continuous efficiency of NHEJ inhibition. Since Uls1 is the only known STUbL with a translocase activity, it can be the general molecular sweeper for the clearance of polySUMOylated proteins on DNA in eukaryotes.
Introduction
Inhibition of the non-homologous end joining (NHEJ) repair pathway at telomeres ensures that chromosome ends do not fuse (Jain and Cooper, 2010) . The necessity to be continuously efficient is a key feature of NHEJ inhibition at telomeres since a temporary lapse at two telomeres could result in a telomere fusion. Although this accident is sometimes reversible (Pobiega and Marcand, 2010) , it poses a major challenge to genome stability. Protection against telomere fusions depends mostly on preventing fusions from occurring. Proteins bound to telomeric repeated sequences establish this strong cisinhibition. Its strength and reliability are the result of in part the multiplicity of DNA-bound molecules at each telomere and in part the synergy between several pathways of inhibition. In fission yeast, telomere repeats are bound by multiple Taz1 proteins that recruit Rap1 proteins. Both factors are required for NHEJ inhibition (Miller et al, 2005; Fujita et al, 2012) . In mammals, NHEJ inhibition is established by the binding of multiple TRF2 proteins to the double-stranded telomere repeats (van Steensel et al, 1998; Celli and de Lange, 2005; Bae and Baumann, 2007; Sfeir and de Lange, 2012) . Mammalian RAP1, recruited to telomeres by TRF2, is not essential for NHEJ inhibition (Sfeir et al, 2010) . Nevertheless, an artificial targeting of RAP1 to telomeres lacking TRF2 is sufficient to inhibit NHEJ, suggesting that TRF2 establishes several redundant pathways including one involving RAP1 (Sarthy et al, 2009 ). In the budding yeast Saccharomyces cerevisiae, Rap1 binds telomeric DNA directly and establishes three genetically separable pathways to inhibit NHEJ (Marcand et al, 2008) . Rap1 also protects telomere ends from 5 0 to 3 0 degradation and checkpoint signalling, and limits telomere elongation by telomerase (Teixeira et al, 2004; Negrini et al, 2007; Bonetti et al, 2010; Vodenicharov et al, 2010; Anbalagan et al, 2011; McGee et al, 2011; Ribeyre and Shore, 2012) . In addition to its role at telomeres, Rap1 binds a large number of gene promoters where it plays an essential role in transcription (Lickwar et al, 2012) .
In S. cerevisiae, the loss of the protein Uls1 results in a negative synthetic interaction with a rap1 hypomorphic allele, suggesting a link between Uls1 and Rap1 functions (Costanzo et al, 2010) . Uls1 (also called Ris1, Dis1 or Tid4) is a non-essential Swi2/Snf2-related translocase exhibiting a DNA-dependent ATPase activity (Zhang and Buchman, 1997; Shah et al, 2010) . It interacts genetically with several genes required for homologous recombination (Collins et al, 2007; Costanzo et al, 2010; Shah et al, 2010; Cal-Bakowska et al, 2011) and homologous recombination was proposed to be a target for Uls1 translocase (Chi et al, 2011) . Uls1 is also a Small Ubiquitin-related MOdifier (SUMO)-Targeted Ubiquitin Ligase (STUbL) (Uzunova et al, 2007) . SUMOylation is a regulatory reversible posttranslational modification linking the SUMO carboxyterminus and the e-amino group of a lysine in the target protein. Poly-SUMO chains can be formed through the SUMOylation of SUMO monomers (Bylebyl et al, 2003; Ulrich, 2008; Sun and Hunter, 2012) . In budding yeast, two STUbLs Uls1 and Slx5/Slx8 recognize and ubiquitinylate for proteosomal degradation proteins conjugated to poly-SUMO chains (Uzunova et al, 2007; Xie et al, 2007; Mullen and Brill, 2008; Nagai et al, 2008; Ulrich, 2008) . Proteins targeted by Uls1 remain to be identified.
The genetic interaction between uls1 and rap1 encouraged us to address a potential function of Uls1 at telomeres. Several studies have linked SUMO and telomere functions (Askree et al, 2004; Zhao and Blobel, 2005; Potts and Yu, 2007; Xhemalce et al, 2007; Rog et al, 2009; Ferreira et al, 2011) . For instance, SUMOylation of yeast telomere single-strand binding protein Cdc13 regulates its interaction with its partner Stn1 to limit telomere elongation by telomerase during S phase . Since cells lacking Uls1 display normal telomere length (Askree et al, 2004) , we addressed a defect in NHEJ inhibition. Here, we show that Uls1 activities are required for the maintenance of NHEJ inhibition at telomeres through the clearance of non-functional poly-SUMOylated Rap1 molecules.
Results

Loss of Uls1 causes telomere fusions by NHEJ
To address a defect in NHEJ inhibition at telomeres in cells lacking Uls1, we looked at the appearance of telomere fusions, which can to some extent be amplified by PCR despite their palindromic structures (Mieczkowski et al, 2003; Pardo and Marcand, 2005) . All S. cerevisiae chromosome ends display a conserved X subtelomeric element. About half the chromosome ends contain one or several Y 0 subtelomeric elements inserted between the X element and the telomere. We used two primers to amplify fusions between Y 0 and X-only telomeres ( Figure 1A ). Cells were grown exponentially and then allowed to reach stationary phase. As shown in Figure 1B (top panel, 30 PCR cycles), telomere fusions are not detected in wild-type cells nor in uls1-D exponentially growing cells but are detected in stationary cells lacking Uls1. Telomere length being heterogeneous, amplified telomere fusions appear as a smeared signal. The lengths of the PCR products indicate that the mean length of telomeric repeats in the fusions is B500 bp, a length consistent with fusions occurring between telomeres close to the mean telomere length (B300 bp). Dilution of the template DNA provides a semi-quantitative estimation of the method's sensitivity ( Figure 1B , second panel from top, 34 PCR cycles; rarer fusions are amplified as discrete bands). The relative lack of fusions in growing uls1-D cells could either be due to a continuous counter-selection of fused chromosomes or a reduced fusion frequency or both. In the following experiments, the presence of telomere fusions was tested in cells in stationary phase.
To determine which repair pathway fuses telomeres, we combined the uls1-D mutant with an NHEJ defective lif1-D mutant. Lif1 loss suppresses the fusions caused by Uls1 loss ( Figure 1C ), indicating that fusions are produced by NHEJ. Thus, Uls1 is required for NHEJ inhibition at telomeres. To estimate how severely Uls1 loss challenges NHEJ inhibition, we compared the frequency of telomere fusions between uls1-D and rap1-(D) cells. The rap1-(D) mutant is a degron allele of RAP1. In rap1-(D) cells reaching stationary phase, Rap1 level drops and telomeres fuse at an approximate frequency of one fusion per cell (Pardo and Marcand, 2005; Pobiega and Marcand, 2010) . As shown in Figure 1D , telomere fusions are detected in rap1-(D) cells with a lower number of PCR cycles than in uls1-D cells. A semi-quantitative estimation indicates that fusions are about a hundred times less frequent in uls1-D cells than in rap1-(D) cells in stationary phase, indicating that, relative to Rap1 loss, Uls1 loss causes a mild defect of NHEJ inhibition at telomeres.
Uls1 translocase and ubiquitin ligase activities are involved in NHEJ inhibition at telomeres
We next asked which activities of Uls1 are involved in NHEJ inhibition at telomeres (Figure 2A ). The Uls1 protein possesses an ubiquitin E3 ligase RING domain and a Swi2/Snf2-like ATPase/translocase domain in its carboxy-terminal part (Zhang and Buchman, 1997; Uzunova et al, 2007; Shah et al, 2010) . At least four SUMO-interacting motifs (SIM) are present in the amino-terminal region of the protein (Uzunova et al, 2007 ). An allele mutated within these SIMs still interacts with SUMO in a yeast two-hybrid assay (data not shown), suggesting that Uls1 may possess additional, less canonical SIMs that remain to be located (Sun and Hunter, 2012; Vogt and Hofmann, 2012) . In the central region, we identified a new tandem domain that we propose to call REPULS for 'Repeats in Uls1'. Variable number of this domain is present in Uls1 sequences from other hemisascomycetes including Kluyveromyces lactis and Ashbya gossypii but is missing in the putative Uls1 orthologues from the more distantly related species Debaromyces hansenii and Schizosaccharomyces pombe (Figure 2A ; Supplementary data).
To address the contribution of Uls1 ubiquitin E3 ligase activity, the second cysteine of the RING domain at position 1333 was mutated to a serine (Uzunova et al, 2007) . To knocked down Uls1 translocase activity, the catalytic lysine at position 975 was mutated to an arginine. In cells carrying either mutation at the endogenous uls1 locus, telomere fusions are detected. Although an effect of these point mutations on protein folding cannot be ruled out, this result suggests that both enzymatic activities of Uls1 are required for efficient NHEJ inhibition at telomeres ( Figure 2B ). The slightly lower frequencies of fusions observed in both mutants relative to the frequency observed in uls1-D cells indicate that each knock-down activity may not be systematically employed by Uls1 or that the point mutants conserve some enzymatic activity. To investigate REPULS domains involvement in NHEJ inhibition at telomeres, an uls1-D677-855 allele lacking the tandem domains was created and integrated at the endogenous uls1 locus. This mutant displays normal growth and telomere length (data not shown) and telomere fusions remain undetectable ( Figure 2C ). The simplest interpretation of this result is that the REPULS domains are not involved or are facultative in Uls1 function at telomeres. A more complicated possibility we cannot rule out is that the truncated uls1-D677-855 protein displays an aberrant activity that suppresses the occurrence of telomere fusions indirectly.
To further address the phenotype of these uls1 alleles, we tested their ability to complement an uls1 deletion. The wildtype and mutant uls1 genes were inserted at an ectopic position in an uls1-D strain. The presence of a wild-type or an uls1-D677-855 sequence abolishes the telomere fusions caused by the uls1 deletion ( Figure 2D ). By contrast, the presence of an uls1-K975R or uls1-C1333S sequence has no obvious effect on the frequency of telomere fusions (a twofold difference or less would be below the assay sensitivity). A synergy between these two point mutants and a mild expression defect caused by the ectopic position might explain the stronger phenotype observed in this situation compared to the situation where the same mutants are integrated at the endogenous ULS1 locus. Together, these results support the hypothesis that Uls1 function at telomeres involves its translocase and ubiquitin ligase activities and that the REPULS domains are facultative for this function.
Uls1 requirement for NHEJ inhibition suggests that the protein might be present at telomeres. We tested this possibility by cross-linked Chromatin Immuno-Precipitation (ChIP) directed against an epitope-tagged variant of Uls1. As shown in Figure 2E , sequences immediately adjacent to the X telomere TEL 6R and to the Y 0 telomeres are specifically pulled down with Uls1. Sequences at an internal locus (LYS2) and 3 kb away from telomere within the Y 0 subtelomeric elements are not significantly enriched. This shows that Uls1 is present at the tips of the chromosomes and suggests that Uls1 activities may target other proteins at telomeres.
The absence of poly-SUMOylation bypasses Uls1 requirement
In cells lacking Uls1, unidentified poly-SUMOylated proteins that would normally be degraded become detectable (Uzunova et al, 2007) . We asked whether the role of Uls1 in NHEJ inhibition at telomeres is linked to its ability to downregulate poly-SUMOylated proteins. In S. cerevisiae, a single gene, SMT3, encodes SUMO. SUMO polymerization occurs on three amino-terminal lysines of Smt3 at positions K11, K15 and K19. In the smt3-3R allele, these SUMOylatable lysines of SUMO are mutated to arginine, preventing poly-SUMO chains but preserving the essential functions of SUMO (Bylebyl et al, 2003; Ulrich, 2008) . Since the smt3-3R allele suppresses the accumulation of polySUMOylated proteins in cells lacking Uls1 (Uzunova et al, 2007) , we looked at telomere fusions in cells carrying this allele, either alone or in combination with an uls1 deletion. As shown in Figure 3A , telomere fusions remain undetectable in smt3-3R cells. However, the smt3-3R allele abolishes the fusions caused by Uls1 loss. The smt3-3R allele could downregulate NHEJ globally. To address this possibility, we introduced the smt3-3R mutant in a rap1-(D) strain. As shown in Figure 3B , telomere fusions still occur in rap1-(D) smt3-3R double mutant cells. This indicates that NHEJ remains active in the smt3-3R context and that smt3-3R must suppress uls1 deletion by restoring NHEJ inhibition at telomeres. Hence in the absence of poly-SUMO chains Uls1 is no longer needed for NHEJ inhibition. This suggests that poly-SUMOylated proteins are in part responsible for the NHEJ inhibition defect caused by Uls1 loss.
SUMOylation requires an E1 activating enzyme, an E2 conjugating enzyme and one of several SUMO E3 ligases (Ulrich, 2008) . We tested whether the SUMO E3 ligases Siz1 and Siz2 might be part of the activities counteracted by Uls1. As shown in Figure 3C , Siz1 loss suppresses the occurrence of telomere fusions in cells lacking Uls1. Siz2 loss causes a more limited suppression. Thus, a SUMOylation defect bypasses the need for Uls1 at telomeres, further suggesting that SUMOylated proteins perturb NHEJ inhibition in the absence of Uls1.
A synthetic negative interaction between uls1-D and a rap1 hypomorphic allele is suppressed by smt3-3R A systematic study revealed previously a negative synthetic interaction between an uls1 deletion and a hypomorphic allele of rap1 created by the 'Decreased Abundance by mRNA Perturbation' (DAmP) method (Yan et al, 2008; Costanzo et al, 2010) . In this rap1-DAmP allele, RAP1 coding sequence is separated from its native 3 0 UTR. As shown in Figure 3D , rap1-DAmP and uls1-D single mutant cells grow as well as wild-type cells but double mutant rap1-DAmP uls1-D cells grow slightly slower, reproducing in our W303 genetic background the negative synthetic interaction initially observed in a BY4147 background. This growth defect is unaffected by an NHEJ-defective lif1-D mutant but is suppressed by the smt3-3R allele. Thus, the negative interaction between uls1 and rap1 requires polySUMOylated proteins. The rap1-DAmP allele does not significantly reduced relative Rap1 protein level ( Figure 3E ). Loss of the native 3 0 UTR may alter translation quality. We checked the occurrence of telomere fusions in these cells once they reached stationary phase ( Figure 3F ). Telomere fusions remain undetectable in rap1-DAmP single mutant cells and the frequency of fusions caused by Uls1 loss is not increased by the rap1-DAmP allele. Their occurrence is suppressed by Lif1 loss and by the smt3-3R allele. The average telomere length remains unchanged in these mutant cells (data not shown).
The negative interaction between uls1-D and rap1-DAmP is not a consequence of telomere fusions since fusions only occur in a small fraction of cells in stationary phase.
Furthermore, this negative interaction is not suppressed by a loss of NHEJ. Its cause might be an unidentified telomere defect or a perturbation of transcription from one or several of the many essential genes whose promoter is bound and regulated by Rap1 (Lickwar et al, 2012) . In both scenarios and in agreement with the telomere fusions caused by Uls1 loss, Rap1 function might be perturbed in the absence of Uls1 either directly or indirectly through poly-SUMOylation. Rap1 is SUMOylated at a low level in normal growth condition . This encouraged us to address the hypothesis of a direct perturbation of Rap1 by SUMO.
Suppression of uls1-D by rap1 alleles
If the poly-SUMOylation of Rap1 is responsible of NHEJ inhibition failure at telomeres in cells lacking Uls1, then a non-SUMOylatable allele of rap1 should suppress this defect. Rap1 displays three distinct and conserved domains: a BRCT domain in its amino-terminal region, a central DNA-binding domain (DBD) and a carboxy-terminal domain called RCT that is unique to Rap1 and its orthologues in other species ( Figure 4A ) (Chen et al, 2011; Matot et al, 2012) . Only Rap1 DBD and RCT domain are required for NHEJ inhibition at telomeres (Marcand et al, 2008) . The function of its aminoterminal region, which includes the BRCT domain, remains to be identified. We first tested whether a deletion of this nonessential part of Rap1 could suppress Uls1 loss. Two truncation mutants were introduced in uls1-D cells: rap1-D2-228 and rap1-D2-309. Position 228 is the edge of the BRCT domain and position 309 is the last lysine residue before the essential DBD. In uls1-D cells where the first 228 amino acids of Rap1 are missing, telomere fusions still occur but extension of the deletion to amino acid 309 strongly reduces the frequency of telomere fusions ( Figure 4B ). The average telomere length is shortened by about 50 bp in these rap1 mutant cells (data not shown).
Between positions 228 and 309 of Rap1, a sequence close to the most common SUMOylation consensus CKXE/D (C: bulky hydrophobic residue) is present around lysine 246 ( Figure 4A ). The position of this lysine suggests that it could be a SUMOylation site whose loss in the rap1-D2-309 mutant contributes to uls1-D suppression. To test this hypothesis, lysine 246 was mutated to a non-SUMOylatable arginine in full-length Rap1. This rap1-1R allele strongly reduces the frequency of telomere fusions caused by Uls1 loss ( Figure 4C ). A few telomere fusions are still detected in uls1-D rap1-1R cells. The additional mutation of nearby lysine and Lev791 and Lev792 (uls1-D677-855) were grown to stationary phase. Telomere fusions were amplified with 30 and 34 cycles. (D) Complementation of uls1-D by ULS1 wild-type and mutant alleles. Strain 210-5b (uls1-D) was transformed with StuI-digested plasmids pRS406, pRS406-uls1-K975R, pRS406-uls1-C1333S and pRS406-uls1-D677-855 and with MfeI-digested plasmid pRS404-ULS1. Cultures of two independent transformants were grown to stationary phase in rich medium. Telomere fusions were amplified with 26 and 30 cycles. (E) Uls1 is present at telomeres. Uls1 was tagged with 13 myc epitopes in the C-terminal position (Uls1-myc). A wild-type strain with untagged Uls1 was used as a control ( À ). Distances of the primer pairs from the terminal TG 1-3 repeats are indicated. LYS2 is an internal non-telomeric locus. ChIP assay was performed as described by Guglielmi et al (2007) . Immunoprecipitated and input DNA were quantified by qPCR. ChIP signal was normalized to input DNA. Data shown are the mean and standard deviation of three independent experiments. 240 to arginine (rap1-2R) further reduces this very low level of fusions ( Figure 4C ; data not shown), suggesting that SUMOylation at lysine 240 might contribute to the weak NHEJ inhibition defect observed in uls1-D rap1-1R cells. The average telomere length remains unchanged in these mutant cells (data not shown). Although these results do not rule out SUMOylation at other lysines in Rap1 or that SUMOylation of other proteins contributes to the uls1-D phenotype, they indicate that NHEJ inhibition failure in the absence of Uls1 is in part due to Rap1 SUMOylation at lysines 240 and 246.
Increased level of poly-SUMOylated Rap1 in uls1-D cells
A prediction of the previous results is that SUMOylated Rap1 molecules accumulate in uls1-D cells. SUMOylated proteins are rare and their detection often requires an enrichment step. To detect SUMOylated Rap1, we used a method described by Ulrich and Davies (2009) . In short, His-tagged SUMO expressed in vivo allows the bulk purification of SUMOylated proteins under denaturing conditions by Ni-NTA pull-down. The presence of a particular SUMO conjugate can then be detected by western blot analysis. Rap1 SUMOylation was tested in exponentially growing cells (Figure 5, upper panel) and in stationary cells (lower panel). As previously observed , Rap1 is SUMOylated in wild-type cells, mostly as mono-SUMO conjugates ( Figure 5 ; filled circle). In cells lacking Uls1, the level of SUMOylated Rap1 increases, mostly as poly-SUMO conjugates (stars), indicating that Uls1 is required to limit the accumulation of poly-SUMOylated Rap1 molecules. In rap1-2R cells, poly-SUMOylated Rap1 molecules are less frequent, indicating that a large fraction of the Rap1 poly-SUMO conjugates are linked to lysines 240 and 246. The persistence of mono-and some poly-SUMO conjugates in rap1-2R cells reveals that, in addition to lysines 240 and 246, other Rap1 lysines can be SUMOylated. Together, these observations reinforce the notion that Uls1 addresses the consequences of polySUMOylated Rap1 molecules by eliminating these conjugates.
Synergy between Uls1 and Sir4
Several pathways synergize to inhibit NHEJ at telomeres. The Rap1 C-terminal domain establishes two parallel inhibitory pathways through the proteins Rif2 and Sir4. In addition, the essential central part of Rap1 inhibits NHEJ independently of Rif2 and Sir4 (Marcand et al, 2008) . As shown previously, fusions are detected in rif2-D sir4-D double mutant cells ( Figure 6A , lower panel). They are detected as longer PCR products than in uls1-D cells, a consequence of the telomere elongation caused by Rif2 loss (Supplementary Figure S2) . To know whether Uls1 is linked to these pathways, we tested the genetic interactions between deletions of ULS1, RIF2 and SIR4. As shown in Figure 6A , in uls1-D sir4-D cells and in usl1-D sir4-D rif2-D cells, telomeres fuse more frequently than in uls1-D cells. By contrast, fusions occur slightly less frequently in uls1-D rif2-D cells. Thus in the absence of Uls1, NHEJ inhibition at telomeres still relies on Sir4 but inhibition by Rif2 is lost. Since a rif2 deletion alone is insufficient to cause a detectable level of fusions and since fusions are more frequent in usl1-D sir4-D rif2-D cells than in sir4-D rif2-D cells, the pathway independent of Rif2 and Sir4 is also at least partially defective in the absence of Uls1. The slight decrease in fusion frequency observed in uls1-D rif2-D cells relative to uls1-D cells might be a consequence of telomere elongation and increased Sir4 recruitment caused by Rif2 loss (Wotton and Shore, 1997; Luo et al, 2002; Feeser and Wolberger, 2008; Marcand et al, 2008; Chen et al, 2011) .
Next, we asked whether telomere fusions occurring in uls1-D sir4-D cells are still in part linked to Rap1 poly-SUMOylation. The smt3-3R, rap1-2R and rap1-D2-309 alleles were combined with the uls1-D sir4-D double mutant. As shown in Figure 6B , all three alleles suppress the telomere fusions caused by Uls1 loss in the absence of Sir4, indicating that the bulk of telomere fusions remains a consequence of Rap1 poly-SUMOylation. However, suppression by rap1-2R and rap1-D2-309 is only partial. It is possible that the loss of one NHEJ inhibition pathway sensitizes telomeres to SUMOylation at other sites than Rap1 lysines 240 and 246. Sir4 loss may also expose other SUMOylation sites within Rap1 but this remains to be addressed.
Discussion
In this study, we observed that the SUMO-dependent ubiquitin ligase and translocase Uls1 is required for efficient NHEJ inhibition at telomeres. This requirement is bypassed by the absence of poly-SUMO chains and by Rap1 mutants lacking SUMOylation sites. In addition, Uls1 is required to avoid the accumulation of poly-SUMOylated Rap1 molecules. Together, these results show that the failure to inhibit NHEJ at telomeres in the absence of Uls1 is at least in part the consequence of the accumulation of poly-SUMOylated Rap1 that are normally eliminated by Uls1. Rap1 poly-SUMOylation seems to cause a loss of Rap1 function. A simple model is that when Rap1 poly-SUMOylation occurs on one or several Rap1 molecule(s) bound to DNA at a telomere, it cripples its ability to inhibit NHEJ (Figure 7 ). Uls1 recognizes poly-SUMO chains conjugated to Rap1. Its translocase activity dissociates these molecules from DNA and ubiquitinylation targets them for degradation by the proteasome (Uzunova et al, 2007) . Unmodified Rap1 from the pool of free Rap1 molecules rapidly replace the freed binding sites, re-establishing full protection against NHEJ.
Once bound to DNA, Rap1 detaches slowly in vitro (Williams et al, 2010) . In vivo Rap1 residence time on DNA is estimated to be in the 30-60 min range at telomeres (Lickwar et al, 2012) . If this slow turnover was the only way to lose SUMOylated Rap1 molecules, a telomere could be exposed to NHEJ long enough to create a reasonable probability that another telomere is simultaneously exposed at some point, allowing telomere fusions. Uls1 ATPdependent translocation can prevent it by accelerating the dislodging of these molecules from DNA. Their subsequent ubiquitination and degradation prevent these molecules from rebinding DNA at telomeres or at other sites. In addition, because telomere fusions occurring in non-dividing cells are cumulative events, even low steady levels of SUMOylated Rap1 and relatively infrequent and transient telomere exposure to NHEJ could result in a significant accumulation of fusions over time.
How poly-SUMOylation perturbs Rap1 function is unknown but the requirement for Uls1 translocase activity indicates that Rap1 DNA binding ability must remain significant. Rap1 poly-SUMOylation antagonizes NHEJ inhibition by Rif2 and by the pathway independent of Rif2 and Sir4 but not by the Sir4 pathway, which remains proficient in the absence of Uls1. One possibility is that once at telomeres Sir4 can remain anchored through the silent chromatin and thereby be partially insensitive to a transient Rap1 loss of function. The Sir4-Rap1 complex or the mechanism of NHEJ inhibition by Sir4 may also be specifically insensitive to Rap1 SUMOylation. In all scenarios, the independence between Sir4 and Uls1 adds a level of redundancy that further protects telomeres from NHEJ. The lack of telomere elongation in uls1-D cells despite a loss of Rif2 function in NHEJ inhibition is surprising. Whether Rap1 SUMOylation can perturb Rif2 function in telomere length homeostasis during replication remains unknown. Perhaps in the absence of Uls1 polySUMOylated Rap1 molecules are too rare to influence most telomeres at each replication cycle, thus allowing telomere length homeostasis by functional Rap1 molecules to buffer for the drift of a few telomeres stochastically affected by Rap1 SUMOylation. By contrast, the static nature of telomere fusions may allow the dominance of Rap1 SUMOylation over Rif2 function to manifest itself by the progressive accumulation of telomere fusions. It would be interesting to test this model.
A different issue is whether Rap1 mono-and poly-SUMO conjugates have a positive role in cells. rap1-1R and rap1-2R mutants display normal growth, normal telomere length and no detectable telomere fusion ( Figure 4B ; data not shown). This indicates that SUMOylation at lysines 240 and 246 is not essential for the core Rap1 functions. It does not rule out a positive function for Rap1 SUMOylation that would be redundant with another mechanism or only relevant in contexts that do not often occur in normal growth conditions, for instance situations where Rap1 poly-SUMOylation could rapidly and transiently inactivate Rap1 function. Interestingly, DNA damage induces the hyper-SUMOylation of many proteins including Rap1 (Cremona et al, 2011; Hang et al, 2011) . Maybe the modulation of Rap1 function at telomeres or at promoters helps the cell to cope with DNA damage-induced stress. An alternative possibility is that Rap1 poly-SUMOylation has no biological function and is part of a background of SUMOylation in the cell. In this model, Uls1 role would be to keep low the steady level of unselected poly-SUMO conjugates, Rap1 being one target among others.
Uls1 is the only known STUbL with a translocase activity. It may have a large number of targets and therefore can be in principle the general molecular sweeper for the clearance of poly-SUMOylated proteins on DNA in eukaryotes. Uls1 has previously been implicated in homologous recombination at breaks and at replication forks, functions for which its targets remain to be identified (Zhang and Buchman, 1997; Shah et al, 2010; Cal-Bakowska et al, 2011; Chi et al, 2011) . In addition, the new and yeast-specific REPULS domain we identified in Uls1 and whose functions remain unknown suggests that additional modes of Uls1 regulation or mobilization are likely to exist.
Materials and methods
Yeast strains and plasmids
The strains used in this study are listed in Supplementary Table 1. Mutations within ULS1 and RAP1 were created by overlapping multiple PCRs whose products were assembled to a plasmid by single-strand annealing in yeast. Mutant alleles were recovered, sequenced, cloned into pRS406 and integrated at the endogenous locus by pop-in pop-out selection. Correct integrations were identified by PCR and sequencing. The smt3-3R::TRP1 and rap1-DAmP::KAN r alleles were amplified by PCR from strains GBY1 (a gift from Erica Johnson) and YNL216 (a gift from Jesse Platt and Bradley Johnson) respectively and integrated at their endogenous locus in a W303 wild-type strain.
Amplification of the telomere-telomere fusions by PCR Cells were streaked on rich medium plate (YPD) at 301C for 24 h and then grown in liquid-rich medium at 301C to saturation for 6 days (excepted in Figure 1B where exponentially growing cells were from cultures whose OD 600 nm was maintained below 1 for 24 h). Genomic DNA was extracted with phenol/chloroform and 800-1200 mm acid-washed glass beads, ethanol-precipitated and resuspended in TE pH 8.0 with RNAse A (B10 ng/ml).
Fusions between X and Y 0 telomeres were amplified with primers X2 5 0 -TGTGGTGGTGGGATTAGAGTGGTAG-3 0 and Y 0 2 5 0 -TTAGGGCT ATGTAGAAGTGCTG-3 0 . PCRs (30 ml) contained genomic DNA B10 ng, Phusion HF buffer 1 Â , DMSO 3%, dNTP 200 mM each, primers 0.5 mM each, HotStart Phusion polymerase 0.6 unit (Finnzymes). Reaction mixes were prepared at room temperature. Amplification conditions were 981C 30 s, then 22, 26, 30 or 34 cycles of 981C 10 s, 651C 20 s, 721C 1 min, followed by 721C 5 min, using GeneAmp PCR System 9700 (Applied Biosystems). The products (10 ml) were separated on a 1% agarose gel containing 1 Â Gel Red nucleic acid stain (Biotium). Fluorescence was analysed on a Typhoon imager (GE).
Detection of SUMO conjugates
Cells were transformed with plasmids pRS316 or YEp195-CUP-HisSmt3 (URA3) (Ulrich and Davies, 2009 ). Cells were grown exponentially in synthetic medium lacking uracil followed by 2 h (expo.) or 5 days (stat.) in rich medium (YPD). Extraction and Ni-NTA pull-down of SUMO conjugates were done as described by Ulrich and Davies (2009) . For stationary cells, lysis in NaOH/BME on ice was improved with 0.8 mm zirconium beads and four pulses of 30 s vortex at 41C. Input aliquots and pull-downs were separated in a NuPage Tris-Acetate 3-8% gel (Novex Life Science) and transferred overnight onto a PVDF membrane at 25 V at 41C in 25 mM Tris, 192 
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